
Progression of disease within 2Â years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real life
Sortais, Clara, Lok, Anne, Tessoulin, Benoit, Gastinne, Thomas, Mahé, Béatrice, Dubruille, Viviane, Blin, Nicolas, Touzeau, Cyrille, Moreau, Anne, Bossard, Céline, Peterlin, Pierre, Garnier, Alice,Journal:
Annals of Hematology
DOI:
10.1007/s00277-020-04025-2
Date:
May, 2020
Fichier:
PDF, 790 KB
2020